A
Arbutus Biopharma (ABUS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Arbutus Biopharma (ABUS)
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more
- USD3.18
- USD3.26
- USD3.16
- USD4.73
- -6.70%
- 7M
- 2.99M
- 913.16k
- 659M
- 2.21
- 45.20%
Stock News
yesterday
Google Leads Five Stocks Near Buy Points, Standing Tall In Tricky Market
Yahoo
yesterday
Netflix expected to broaden subscriber base after winning Women’s World Cup bid
MarketWatch
yesterday
4 Tech Titans Will Spend a Combined $300 Billion on Artificial Intelligence (AI) in 2025, According to 1 Wall Street Firm. This Stock Could Be the Biggest Winner.
Yahoo
yesterday
Walmart, GM, Nvidia, Robinhood: All had an award-winning 2024
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
